Front Row Advisors’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.23M | Hold |
5,035
| – | – | 0.42% | 49 |
|
|
2025
Q4 | $1.04M | Sell |
5,035
-107
| -2% | -$21.2K | 0.35% | 50 |
|
|
2025
Q3 | $953K | Sell |
5,142
-9
| -0.2% | -$1.54K | 0.32% | 52 |
|
|
2025
Q2 | $787K | Sell |
5,151
-980
| -16% | -$151K | 0.27% | 55 |
|
|
2025
Q1 | $1.02M | Sell |
6,131
-653
| -10% | -$102K | 0.39% | 50 |
|
|
2024
Q4 | $981K | Sell |
6,784
-112
| -2% | -$17.4K | 0.34% | 52 |
|
|
2024
Q3 | $1.12M | Sell |
6,896
-2,647
| -28% | -$422K | 0.4% | 49 |
|
|
2024
Q2 | $1.39M | Buy |
9,543
+856
| +10% | +$127K | 0.48% | 49 |
|
|
2024
Q1 | $1.37M | Buy |
8,687
+2,192
| +34% | +$349K | 0.51% | 50 |
|
|
2023
Q4 | $1.02M | Sell |
6,495
-2,563
| -28% | -$393K | 0.47% | 52 |
|
|
2023
Q3 | $1.41M | Sell |
9,058
-675
| -7% | -$111K | 0.65% | 46 |
|
|
2023
Q2 | $1.61M | Sell |
9,733
-30
| -0.3% | -$4.84K | 0.72% | 39 |
|
|
2023
Q1 | $1.51M | Sell |
9,763
-296
| -3% | -$47.8K | 0.73% | 39 |
|
|
2022
Q4 | $1.78M | Buy |
10,059
+6
| +0.1% | +$1.04K | 0.92% | 34 |
|
|
2022
Q3 | $1.64M | Sell |
10,053
-67
| -0.7% | -$11.3K | 0.85% | 35 |
|
|
2022
Q2 | $1.8M | Sell |
10,120
-13
| -0.1% | -$2.32K | 0.88% | 34 |
|
|
2022
Q1 | $1.8M | Sell |
10,133
-8
| -0.1% | -$1.36K | 0.72% | 44 |
|
|
2021
Q4 | $1.74M | Sell |
10,141
-20
| -0.2% | -$3.27K | 0.65% | 51 |
|
|
2021
Q3 | $1.64M | Hold |
10,161
| – | – | 0.69% | 50 |
|
|
2021
Q2 | $1.81M | Sell |
10,161
-1,246
| -11% | -$206K | 0.74% | 45 |
|
|
2021
Q1 | $1.88M | Sell |
11,407
-15
| -0.1% | -$2.43K | 0.91% | 38 |
|
|
2020
Q4 | $1.8M | Hold |
11,422
| – | – | 0.92% | 36 |
|
|
2020
Q3 | $1.65M | Sell |
11,422
-85
| -0.7% | -$12.6K | 0.87% | 38 |
|
|
2020
Q2 | $1.62M | Sell |
11,507
-319
| -3% | -$46.5K | 1% | 32 |
|
|
2020
Q1 | $1.77M | Buy |
11,826
+570
| +5% | +$80.9K | 1.2% | 25 |
|
|
2019
Q4 | $1.64M | Sell |
11,256
-210
| -2% | -$28.5K | 1.07% | 30 |
|
|
2019
Q3 | $1.48M | Sell |
11,466
-342
| -3% | -$45.1K | 1.06% | 33 |
|
|
2019
Q2 | $1.65M | Sell |
11,808
-354
| -3% | -$49K | 1.2% | 25 |
|
|
2019
Q1 | $1.7M | Sell |
12,162
-2,045
| -14% | -$274K | 1.32% | 18 |
|
|
2018
Q4 | $1.83M | Sell |
14,207
-2,082
| -13% | -$290K | 1.59% | 10 |
|
|
2018
Q3 | $2.24K | Buy |
16,289
+20
| +0.1% | +$2.66K | 1.57% | 8 |
|
|
2018
Q2 | $2.1K | Sell |
16,269
-473
| -3% | -$59K | 1.34% | 10 |
|
|
2018
Q1 | $2.15M | Buy |
16,742
+87
| +0.5% | +$11.8K | 1.5% | 9 |
|
|
2017
Q4 | $2.33M | Buy |
+16,655
| New | +$2.32M | 1.85% | 6 |
|
Other funds holding JNJ
VCM
VPM
Front Row Advisors's JNJ Position: Q1 2026 in Review
Front Row Advisors held its Johnson & Johnson (JNJ) position steady in Q1 2026 at 5,035 shares worth $1.23M. The position accounts for 0.42% of the portfolio, ranked #49.
Front Row Advisors first reported a position in JNJ in Q4 2017 and has held it in 34 quarters since. The position peaked at $2.33M in Q4 2017. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Front Row Advisors held 5,035 shares of Johnson & Johnson worth $1.23M as of Q1 2026.
- Front Row Advisors left its Johnson & Johnson share count unchanged in Q1 2026.
- Johnson & Johnson made up 0.42% of Front Row Advisors's portfolio in Q1 2026, its #49 holding.
- Front Row Advisors first reported a position in Johnson & Johnson in Q4 2017 and has held it in 34 quarters since.
- Front Row Advisors's Johnson & Johnson position peaked at $2.33M in Q4 2017.
- 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Front Row Advisors's 13F filing for Q1 2026, filed 19 May 2026.